Jupiter Life Line Hospitals Limited (NSE:JLHL)
India · Delayed Price · Currency is INR | Market Cap | 93.64B -5.6% |
| Revenue (ttm) | 16.21B +17.9% |
| Net Income | 1.86B -6.2% |
| EPS | 5.69 -6.2% |
| Shares Out | 327.83M |
| PE Ratio | 50.22 |
| Forward PE | 43.13 |
| Dividend | 0.20 (0.07%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | 75,070 |
| Open | 289.35 |
| Previous Close | 286.50 |
| Day's Range | 280.15 - 293.15 |
| 52-Week Range | 233.40 - 340.00 |
| Beta | 0.10 |
| Analysts | Strong Buy |
| Price Target | 322.17 (+12.79%) |
| Earnings Date | Oct 23, 2026 |
About NSE:JLHL
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurger... [Read more]
Financial Performance
In fiscal year 2026, NSE:JLHL's revenue was 15.00 billion, an increase of 15.16% compared to the previous year's 13.02 billion. Earnings were 1.94 billion, an increase of 0.42%.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for JLHL stock is "Strong Buy." The 12-month stock price target is ₹322.17, which is an increase of 12.79% from the latest price.
News
Jupiter Life Line Hospitals Transcript: Q2 26/27
Q2 income was INR 456.5 crore and PAT INR 56.4 crore, with Dombivli nearing EBITDA breakeven amid seasonal support and organic growth. Pune land acquisition and three live expansion projects underpin investment plans; debt is capped internally at 3x EBITDA.
Jupiter Life Line Hospitals Quarterly report: Q2 2027
Jupiter Life Line Hospitals has published its Q2 2027 quarterly earnings report on October 26, 2026.
Jupiter Life Line Hospitals Slides: Q2 2027
Jupiter Life Line Hospitals has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on October 26, 2026.
Jupiter Life Line Hospitals Transcript: Q1 26/27
Q1 FY27 saw revenue of INR 411 crore, EBITDA of INR 79.3 crore (19.3% margin), and PAT of INR 37.5 crore, with Dombivli Hospital's ramp-up impacting margins as expected. Mature units are stable, while new projects and backward integration initiatives support future growth.
Jupiter Life Line Hospitals Quarterly report: Q1 2027
Jupiter Life Line Hospitals has published its Q1 2027 quarterly earnings report on August 3, 2026.
Jupiter Life Line Hospitals Slides: Q1 2027
Jupiter Life Line Hospitals has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 3, 2026.
Jupiter Life Line Hospitals Transcript: Q4 25/26
FY 2026 saw strong 15%+ growth in revenue and EBITDA, with robust expansion plans adding 1,700 beds across Mumbai and Pune. Dombivli hospital opened ahead of schedule, and the group remains cash positive, funding growth through internal accruals and capped debt.
Jupiter Life Line Hospitals Quarterly report: Q4 2026
Jupiter Life Line Hospitals has published its Q4 2026 quarterly earnings report on May 15, 2026.
Jupiter Life Line Hospitals Slides: Q4 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 15, 2026.
Jupiter Life Line Hospitals Annual report: Q4 2026
Jupiter Life Line Hospitals has published its Q4 2026 annual report on May 15, 2026.
Jupiter Life Line Hospitals Transcript: Q3 25/26
Dombivli hospital launched ahead of schedule, but will initially weigh on margins as it ramps up. Q3 saw 9.8% revenue growth and stable EBITDA margins, though PAT declined due to a one-time labor code provision. Mature hospitals are stable, while Indore and new projects drive future growth.
Jupiter Life Line Hospitals Quarterly report: Q3 2026
Jupiter Life Line Hospitals has published its Q3 2026 quarterly earnings report on January 30, 2026.
Jupiter Life Line Hospitals Slides: Q3 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 30, 2026.
Jupiter Life Line Hospitals Transcript: Q2 25/26
Q2 and H1 FY26 saw double-digit revenue and EBITDA growth, with margins stable despite new bed additions. Dombivli Hospital is on track for Q1 launch next year, with new accounting for unbilled revenue and a one-off provision impacting results. Debt remains low-cost and well-covered by liquidity.
Jupiter Life Line Hospitals Quarterly report: Q2 2026
Jupiter Life Line Hospitals has published its Q2 2026 quarterly earnings report on November 7, 2025.
Jupiter Life Line Hospitals Slides: Q2 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 7, 2025.